Company Information for MISSION THERAPEUTICS LIMITED
BABRAHAM HALL, BABRAHAM, CAMBRIDGE, CB22 3AT,
|
Company Registration Number
![]() Private Limited Company
Active |
Company Name | |
---|---|
MISSION THERAPEUTICS LIMITED | |
Legal Registered Office | |
BABRAHAM HALL BABRAHAM CAMBRIDGE CB22 3AT Other companies in CB22 | |
Company Number | 07630933 | |
---|---|---|
Company ID Number | 07630933 | |
Date formed | 2011-05-11 | |
Country | ||
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 31/12/2023 | |
Account next due | 30/09/2025 | |
Latest return | 11/05/2016 | |
Return next due | 08/06/2017 | |
Type of accounts | FULL |
Last Datalog update: | 2024-06-05 07:33:17 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Registered address | Last known status | Formation date | ||
---|---|---|---|---|
![]() |
MISSION THERAPEUTICS INC | Delaware | Unknown | |
![]() |
MISSION THERAPEUTICS INCORPORATED | California | Unknown |
Officer | Role | Date Appointed |
---|---|---|
DAVID LUTHER |
||
MARIA GABRIELLA CAMBONI |
||
COLIN GODDARD |
||
DEBORAH HARLAND |
||
IP2IPO SERVICES LIMITED |
||
STEPHEN PHILIP JACKSON |
||
ELAINE JONES |
||
ANKER LUNDEMOSE |
||
MICHAEL MOORE |
||
CAROLE NUECHTERLEIN |
||
GRAZIANO SEGHEZZI |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
ROBBIE WOODMAN |
Director | ||
TRACY SAXTON |
Director | ||
ANDREW MUNCEY |
Company Secretary | ||
THEODORA HAROLD |
Company Secretary | ||
SIMON CHRISTOPHER KERR |
Director | ||
FRITZ-FRIEDER KARL GEORG FRICKEL |
Director | ||
KEITH STUART BLUNDY |
Director | ||
ANDREW JONATHAN WALDRON |
Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
BICYCLE THERAPEUTICS PLC | Director | 2017-12-04 | CURRENT | 2017-10-27 | Active | |
BICYCLETX LIMITED | Director | 2017-12-04 | CURRENT | 2017-10-27 | Active | |
PROGENITOR LABS LIMITED | Director | 2017-02-16 | CURRENT | 2010-02-12 | Active | |
CANCER RESEARCH TECHNOLOGY LIMITED | Director | 2015-09-30 | CURRENT | 1982-03-31 | Active | |
F-STAR BETA LIMITED | Director | 2014-10-14 | CURRENT | 2014-10-14 | Liquidation | |
VHSQUARED LIMITED | Director | 2013-12-11 | CURRENT | 2010-06-16 | Liquidation | |
F-STAR ALPHA LIMITED | Director | 2013-10-08 | CURRENT | 2013-09-04 | Liquidation | |
BICYCLERD LIMITED | Director | 2009-12-07 | CURRENT | 2009-07-13 | Active | |
CONCIRRUS LTD | Director | 2018-07-23 | CURRENT | 2011-09-30 | Active | |
ARTIOS PHARMA LIMITED | Director | 2018-06-25 | CURRENT | 2015-12-29 | Active | |
CRYSALIN LIMITED | Director | 2018-06-21 | CURRENT | 2007-04-27 | Liquidation | |
SILICON MICROGRAVITY LIMITED | Director | 2018-06-06 | CURRENT | 2014-09-16 | Active | |
IESO DIGITAL HEALTH LIMITED | Director | 2018-04-26 | CURRENT | 2000-09-01 | Active | |
PERACHEM HOLDINGS PLC | Director | 2018-04-26 | CURRENT | 2005-04-15 | Liquidation | |
NEXEON LIMITED | Director | 2018-04-18 | CURRENT | 2006-02-22 | Active | |
EPSILON-3 BIO LIMITED | Director | 2018-04-16 | CURRENT | 2010-06-18 | Liquidation | |
APCINTEX LIMITED | Director | 2018-04-05 | CURRENT | 2014-06-16 | Active | |
KUUR THERAPEUTICS LIMITED | Director | 2018-03-28 | CURRENT | 2005-11-11 | Liquidation | |
OXFORD BIOTRANS LIMITED | Director | 2018-03-27 | CURRENT | 2013-08-14 | Active | |
OXULAR LIMITED | Director | 2018-03-27 | CURRENT | 2014-11-27 | Active | |
WAVE OPTICS LIMITED | Director | 2018-03-26 | CURRENT | 2012-09-05 | Active | |
TELECTICA LTD | Director | 2018-03-22 | CURRENT | 2012-12-11 | Active | |
TEYA REWARDS LTD. | Director | 2018-03-21 | CURRENT | 2013-05-03 | Active | |
IMPRESSION TECHNOLOGIES LIMITED | Director | 2018-03-13 | CURRENT | 2012-03-30 | Active | |
COVENTRY INTERNATIONAL PRESSING COMPANY LTD | Director | 2018-03-13 | CURRENT | 2015-02-02 | Active | |
PULMOCIDE LIMITED | Director | 2018-03-12 | CURRENT | 2007-03-23 | Active | |
CARDIAN LIMITED | Director | 2018-03-12 | CURRENT | 2016-12-21 | Liquidation | |
AUTIFONY THERAPEUTICS LIMITED | Director | 2018-03-12 | CURRENT | 2011-02-25 | Active | |
INIVATA LIMITED | Director | 2018-03-07 | CURRENT | 2014-07-23 | Active | |
SAM LABS LTD. | Director | 2018-02-28 | CURRENT | 2014-04-23 | Active | |
STORM THERAPEUTICS LIMITED | Director | 2018-02-14 | CURRENT | 2015-04-21 | Active | |
ECONIC TECHNOLOGIES LTD | Director | 2018-02-14 | CURRENT | 2011-06-24 | Active | |
SPIREA LIMITED | Director | 2017-12-14 | CURRENT | 2015-10-09 | Active | |
MOA TECHNOLOGY LIMITED | Director | 2017-10-25 | CURRENT | 2017-08-02 | Active | |
PANCREGENESIS LIMITED | Director | 2017-10-17 | CURRENT | 2017-10-17 | Active - Proposal to Strike off | |
QUANTUM MOTION TECHNOLOGIES LIMITED | Director | 2017-08-11 | CURRENT | 2017-07-14 | Active | |
CHROMOSOL LIMITED | Director | 2017-06-09 | CURRENT | 2017-06-09 | Liquidation | |
EDGETIC LIMITED | Director | 2017-05-15 | CURRENT | 2017-05-15 | Liquidation | |
ALESI SURGICAL LIMITED | Director | 2017-03-02 | CURRENT | 2007-03-01 | Active | |
ART OF XEN LIMITED | Director | 2017-02-22 | CURRENT | 2001-06-15 | Active | |
ACCELERCOMM LTD | Director | 2016-12-21 | CURRENT | 2016-03-04 | Active | |
MICROBIOTICA LIMITED | Director | 2016-12-15 | CURRENT | 2016-07-08 | Active | |
CELLTRON NETWORKS LIMITED | Director | 2016-10-19 | CURRENT | 2016-10-19 | Active - Proposal to Strike off | |
APERIO PHARMA LIMITED | Director | 2016-10-13 | CURRENT | 2016-10-13 | Active - Proposal to Strike off | |
MIXERGY LIMITED | Director | 2016-08-26 | CURRENT | 2014-07-18 | Active | |
UNIPHY LIMITED | Director | 2016-07-11 | CURRENT | 2016-02-12 | Active | |
DYNAMIC VISION SYSTEMS LIMITED | Director | 2016-07-07 | CURRENT | 2014-10-07 | Active - Proposal to Strike off | |
ULTRALEAP HOLDINGS LIMITED | Director | 2016-06-13 | CURRENT | 2016-03-08 | Active | |
DEFENITION LIMITED | Director | 2016-05-11 | CURRENT | 2016-05-11 | Active | |
CERYX MEDICAL LIMITED | Director | 2016-05-03 | CURRENT | 2016-02-12 | Active | |
PULMONIR LIMITED | Director | 2016-03-15 | CURRENT | 2016-02-02 | Active - Proposal to Strike off | |
ASTERION LIMITED | Director | 2016-03-08 | CURRENT | 2000-12-21 | Active | |
FLUID PHARMA LTD | Director | 2016-03-03 | CURRENT | 2016-03-03 | Active | |
ZEETTA NETWORKS LIMITED | Director | 2015-12-22 | CURRENT | 2015-01-20 | Active | |
NAVENIO LIMITED | Director | 2015-12-04 | CURRENT | 2015-10-28 | Active | |
ADJUVANTIX LIMITED | Director | 2015-10-09 | CURRENT | 1999-10-28 | Dissolved 2016-07-12 | |
RELITECT LIMITED | Director | 2015-02-20 | CURRENT | 2014-11-17 | Active - Proposal to Strike off | |
8POWER LIMITED | Director | 2015-01-20 | CURRENT | 2015-01-20 | Active | |
PHASE FOCUS LIMITED | Director | 2014-12-17 | CURRENT | 2006-06-23 | Active | |
ULTRAMATIS LIMITED | Director | 2014-11-19 | CURRENT | 2014-11-19 | Active - Proposal to Strike off | |
DUKOSI LIMITED | Director | 2014-11-19 | CURRENT | 2003-11-27 | Active | |
MAGNOMATICS LIMITED | Director | 2014-11-07 | CURRENT | 2006-07-17 | Active | |
PERPETUUM LIMITED | Director | 2014-10-01 | CURRENT | 2004-06-04 | Active - Proposal to Strike off | |
EIGHT19 LIMITED | Director | 2014-09-22 | CURRENT | 2010-07-22 | Active | |
UMIP PROJECT 001 LIMITED | Director | 2014-07-29 | CURRENT | 2014-07-29 | Dissolved 2016-09-06 | |
UMIP PROJECT 003 LIMITED | Director | 2014-07-29 | CURRENT | 2014-07-29 | Active - Proposal to Strike off | |
BOXARR LIMITED | Director | 2014-07-24 | CURRENT | 2003-08-20 | Active | |
EXTRAJECT TECHNOLOGIES LTD | Director | 2014-07-23 | CURRENT | 2013-01-21 | Active | |
MEDELLA THERAPEUTICS LIMITED | Director | 2014-07-23 | CURRENT | 2007-02-08 | Active - Proposal to Strike off | |
PH THERAPEUTICS LIMITED | Director | 2014-07-23 | CURRENT | 2013-03-06 | Active | |
UMIP PROJECT 002 LIMITED | Director | 2014-07-03 | CURRENT | 2014-07-03 | Dissolved 2017-10-17 | |
CREAVO MEDICAL TECHNOLOGIES LIMITED | Director | 2014-04-01 | CURRENT | 2014-01-31 | Liquidation | |
OXSYBIO LIMITED | Director | 2014-03-03 | CURRENT | 2014-03-03 | Liquidation | |
IONIX ADVANCED TECHNOLOGIES LTD | Director | 2013-12-23 | CURRENT | 2011-08-04 | Active | |
SAW DX LIMITED | Director | 2013-08-12 | CURRENT | 2013-03-11 | Active - Proposal to Strike off | |
SPINETIC ENERGY LIMITED | Director | 2013-05-24 | CURRENT | 2012-05-28 | Liquidation | |
UBIQUIGENT LTD | Director | 2013-04-04 | CURRENT | 2009-07-10 | Active | |
AZURI TECHNOLOGIES LTD | Director | 2012-12-21 | CURRENT | 2012-07-10 | Active | |
PHOTOPHARMICA LIMITED | Director | 2012-12-21 | CURRENT | 2012-12-03 | Dissolved 2018-06-12 | |
OXEHEALTH LIMITED | Director | 2012-09-13 | CURRENT | 2012-07-31 | Active | |
OXFORD DRUG DESIGN LIMITED | Director | 2012-07-10 | CURRENT | 2001-10-17 | Active | |
CRYPTOGRAPHIQ LIMITED | Director | 2012-06-25 | CURRENT | 2012-06-25 | Active - Proposal to Strike off | |
SEREN PHOTONICS LIMITED | Director | 2012-03-06 | CURRENT | 2009-11-04 | Active - Proposal to Strike off | |
PHOTOPHARMICA LEEDS LIMITED | Director | 2011-09-22 | CURRENT | 2001-03-06 | Dissolved 2015-08-18 | |
FIRST LIGHT FUSION LIMITED | Director | 2011-06-30 | CURRENT | 2011-03-08 | Active | |
UNION LIFE SCIENCES LIMITED | Director | 2011-04-14 | CURRENT | 2006-02-16 | Active - Proposal to Strike off | |
ARKIVUM LIMITED | Director | 2011-03-24 | CURRENT | 2011-02-15 | Active | |
ANACAIL LIMITED | Director | 2011-02-23 | CURRENT | 2010-11-03 | Liquidation | |
CH4E LIMITED | Director | 2011-02-18 | CURRENT | 2009-01-07 | Dissolved 2016-10-27 | |
MBS DIRECTOR LIMITED | Director | 2009-09-02 | CURRENT | 2007-05-23 | Active - Proposal to Strike off | |
MBS SECRETARIAL LIMITED | Director | 2009-09-02 | CURRENT | 2007-05-23 | Active - Proposal to Strike off | |
MODERN BIOSCIENCES NOMINEES LIMITED | Director | 2009-08-04 | CURRENT | 2007-06-14 | Active | |
MODERN BIOSCIENCES LIMITED | Director | 2009-06-02 | CURRENT | 2005-04-05 | Active | |
C-CAPTURE LIMITED | Director | 2009-05-21 | CURRENT | 2009-05-21 | Active | |
AMAETHON LIMITED | Director | 2009-04-17 | CURRENT | 2003-07-30 | Liquidation | |
AZELLON LTD | Director | 2009-01-05 | CURRENT | 2007-12-07 | Active - Proposal to Strike off | |
POLAR OLED LTD | Director | 2008-11-26 | CURRENT | 2008-11-26 | Active - Proposal to Strike off | |
ENCOS LIMITED | Director | 2008-11-13 | CURRENT | 2007-04-23 | Dissolved 2017-04-11 | |
IKSUDA THERAPEUTICS LIMITED | Director | 2008-09-04 | CURRENT | 2007-11-21 | Active | |
DISPERSIA LIMITED | Director | 2008-08-01 | CURRENT | 2006-01-31 | Dissolved 2014-05-27 | |
DYECAT LIMITED | Director | 2008-08-01 | CURRENT | 2005-10-03 | Dissolved 2014-05-06 | |
CHAMELIC LIMITED | Director | 2008-08-01 | CURRENT | 2006-02-16 | Dissolved 2015-08-11 | |
STRUCTURE VISION LIMITED | Director | 2008-08-01 | CURRENT | 2003-03-20 | Active | |
SUSTAINABLE RESOURCE SOLUTIONS LIMITED | Director | 2008-07-25 | CURRENT | 2007-04-30 | Dissolved 2015-07-14 | |
RIO AI LIMITED | Director | 2008-04-09 | CURRENT | 1997-10-01 | Active | |
EMDOT LIMITED | Director | 2007-08-02 | CURRENT | 2007-08-02 | Active | |
MDL 2016 LIMITED | Director | 2007-02-22 | CURRENT | 2006-02-10 | Dissolved 2018-03-06 | |
SURREY NANOSYSTEMS LIMITED | Director | 2006-11-28 | CURRENT | 1999-06-02 | Active | |
PHARMINOX LIMITED | Director | 2006-09-15 | CURRENT | 2001-12-28 | Active - Proposal to Strike off | |
CAPSANT NEUROTECHNOLOGIES LIMITED | Director | 2006-06-28 | CURRENT | 2002-06-21 | Liquidation | |
INSMED INNOVATION UK LTD | Director | 2017-08-25 | CURRENT | 2017-08-25 | Active | |
AUTIFONY THERAPEUTICS LIMITED | Director | 2013-02-14 | CURRENT | 2011-02-25 | Active |
Date | Document Type | Document Description |
---|---|---|
Second filing of director appointment of James Summers | ||
CONFIRMATION STATEMENT MADE ON 11/05/24, WITH UPDATES | ||
Director's details changed for Ip2Ipo Services Limited on 2021-12-01 | ||
13/03/24 STATEMENT OF CAPITAL GBP 12077.97 | ||
Memorandum articles filed | ||
Resolutions passed:<ul><li>Resolution passed adopt articles</ul> | ||
13/03/24 STATEMENT OF CAPITAL GBP 9609.6144 | ||
13/03/24 STATEMENT OF CAPITAL GBP 7715.7103 | ||
31/01/24 STATEMENT OF CAPITAL GBP 6236.6061 | ||
29/12/23 STATEMENT OF CAPITAL GBP 6230.2623 | ||
APPOINTMENT TERMINATED, DIRECTOR COLIN GODDARD | ||
APPOINTMENT TERMINATED, DIRECTOR MARIA GABRIELLA CAMBONI | ||
FULL ACCOUNTS MADE UP TO 31/12/22 | ||
APPOINTMENT TERMINATED, DIRECTOR DEBORAH HARLAND | ||
DIRECTOR APPOINTED MATTHEW JAMES FOY | ||
AP01 | DIRECTOR APPOINTED MATTHEW JAMES FOY | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR DEBORAH HARLAND | |
SH01 | 01/12/22 STATEMENT OF CAPITAL GBP 6169.4998 | |
SH01 | 09/09/22 STATEMENT OF CAPITAL GBP 6125.4998 | |
CS01 | CONFIRMATION STATEMENT MADE ON 11/05/22, WITH UPDATES | |
AA | FULL ACCOUNTS MADE UP TO 31/12/21 | |
SH01 | 03/12/21 STATEMENT OF CAPITAL GBP 5960.1068 | |
SH01 | 10/11/21 STATEMENT OF CAPITAL GBP 5956.1068 | |
SH01 | 09/07/21 STATEMENT OF CAPITAL GBP 5948.013 | |
CS01 | CONFIRMATION STATEMENT MADE ON 11/05/21, WITH UPDATES | |
AA | FULL ACCOUNTS MADE UP TO 31/12/20 | |
AP01 | DIRECTOR APPOINTED JONATHAN PAUL HEPPLE | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ERWIN BOOS | |
SH01 | 31/01/21 STATEMENT OF CAPITAL GBP 5911.8698 | |
SH01 | 03/12/20 STATEMENT OF CAPITAL GBP 5740.7131 | |
SH01 | 30/10/20 STATEMENT OF CAPITAL GBP 5717.5881 | |
RES01 | ADOPT ARTICLES 27/07/20 | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
SH01 | 07/07/20 STATEMENT OF CAPITAL GBP 5714.0861 | |
CS01 | CONFIRMATION STATEMENT MADE ON 11/05/20, WITH UPDATES | |
CH01 | Director's details changed for Graziano Seghezzi on 2020-06-12 | |
SH01 | 27/05/20 STATEMENT OF CAPITAL GBP 5139.9011 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/19 | |
SH01 | 26/03/20 STATEMENT OF CAPITAL GBP 5134.3677 | |
AP01 | DIRECTOR APPOINTED ERWIN BOOS | |
SH01 | 04/12/19 STATEMENT OF CAPITAL GBP 5119.9898 | |
RP04CS01 | Second filing of Confirmation Statement dated 11/05/2019 | |
SH01 | 27/09/19 STATEMENT OF CAPITAL GBP 5042.9977 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MICHAEL MOORE | |
CS01 | CONFIRMATION STATEMENT MADE ON 11/05/19, WITH UPDATES | |
CH01 | Director's details changed for Mr Colin Goddard on 2018-07-01 | |
AP01 | DIRECTOR APPOINTED DENIS PATRICK | |
DIRECTOR APPOINTED JIM SUMMERS | ||
TM01 | APPOINTMENT TERMINATED, DIRECTOR ELAINE JONES | |
AA | FULL ACCOUNTS MADE UP TO 31/12/18 | |
SH01 | 10/12/18 STATEMENT OF CAPITAL GBP 5036.5914 | |
SH01 | 25/10/18 STATEMENT OF CAPITAL GBP 5027.3414 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/17 | |
SH01 | 23/07/18 STATEMENT OF CAPITAL GBP 4865.053 | |
LATEST SOC | 20/06/18 STATEMENT OF CAPITAL;GBP 4862.053 | |
SH01 | 15/06/18 STATEMENT OF CAPITAL GBP 4862.053 | |
LATEST SOC | 18/05/18 STATEMENT OF CAPITAL;GBP 4816.2454 | |
CS01 | CONFIRMATION STATEMENT MADE ON 11/05/18, WITH UPDATES | |
AP02 | Appointment of Ip2Ipo Services Limited as director on 2018-02-15 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ROBBIE WOODMAN | |
LATEST SOC | 15/12/17 STATEMENT OF CAPITAL;GBP 4816.2454 | |
SH01 | 01/12/17 STATEMENT OF CAPITAL GBP 4816.2454 | |
ALLOTCORR | Correction of allotment details of form SH01 registered on 29/06/17. Shares allotted on 20/06/17. Barcode X69M6NE1 | |
LATEST SOC | 25/07/17 STATEMENT OF CAPITAL;GBP 4812.7273 | |
RP04SH01 | Second filing of capital allotment of shares GBP4,812.7273 | |
ANNOTATION | Clarification | |
SH01 | 20/06/17 STATEMENT OF CAPITAL GBP 4812.7274 | |
CS01 | CONFIRMATION STATEMENT MADE ON 11/05/17, WITH UPDATES | |
CH01 | Director's details changed for Dr Robbie Woodman on 2017-05-16 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/16 | |
SH01 | 24/01/17 STATEMENT OF CAPITAL GBP 4798.2307 | |
AP01 | DIRECTOR APPOINTED CAROLE NUECHTERLEIN | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR TRACY SAXTON | |
SH01 | 06/12/16 STATEMENT OF CAPITAL GBP 4775.4016 | |
LATEST SOC | 01/09/16 STATEMENT OF CAPITAL;GBP 3688.4452 | |
SH01 | 01/09/16 STATEMENT OF CAPITAL GBP 3688.4452 | |
AR01 | 11/05/16 FULL LIST | |
AA | FULL ACCOUNTS MADE UP TO 31/12/15 | |
RES01 | ADOPT ARTICLES 01/02/2016 | |
LATEST SOC | 08/02/16 STATEMENT OF CAPITAL;GBP 3667.2158 | |
SH01 | 01/02/16 STATEMENT OF CAPITAL GBP 3667.2158 | |
TM02 | APPOINTMENT TERMINATED, SECRETARY ANDREW MUNCEY | |
AP03 | SECRETARY APPOINTED MR DAVID LUTHER | |
AP01 | DIRECTOR APPOINTED MR COLIN GODDARD | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/14 | |
AP01 | DIRECTOR APPOINTED MS TRACY SAXTON | |
LATEST SOC | 11/05/15 STATEMENT OF CAPITAL;GBP 2580.2598 | |
AR01 | 11/05/15 FULL LIST | |
SH01 | 31/12/14 STATEMENT OF CAPITAL GBP 2580.2561 | |
AP01 | DIRECTOR APPOINTED DR ANKER LUNDEMOSE | |
SH01 | 03/11/14 STATEMENT OF CAPITAL GBP 2579.9864 | |
AP01 | DIRECTOR APPOINTED DR MARIA GABRIELLA CAMBONI | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/13 | |
AR01 | 11/05/14 FULL LIST | |
SH01 | 28/02/14 STATEMENT OF CAPITAL GBP 1352.7134 | |
TM02 | APPOINTMENT TERMINATED, SECRETARY THEODORA HAROLD | |
AP03 | SECRETARY APPOINTED ANDREW MUNCEY | |
AP01 | DIRECTOR APPOINTED DR ELAINE JONES | |
RES01 | ADOPT ARTICLES 10/10/2013 | |
SH01 | 15/10/13 STATEMENT OF CAPITAL GBP 1351.8634 | |
AP01 | DIRECTOR APPOINTED ROBBIE WOODMAN | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR SIMON KERR | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/12 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR FRITZ-FRIEDER FRICKEL | |
AR01 | 11/05/13 FULL LIST | |
RES01 | ADOPT ARTICLES 05/09/2012 | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/11 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR KEITH BLUNDY | |
AP01 | DIRECTOR APPOINTED DR MICHAEL MOORE | |
AR01 | 11/05/12 FULL LIST | |
AD01 | REGISTERED OFFICE CHANGED ON 14/05/2012 FROM MEDITRINA BRABHAM RESEARCH CAMPUS CAMBRIDGE CB22 3AT | |
AP01 | DIRECTOR APPOINTED DR FRITZ-FRIEDER FRICKEL | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES01 | ADOPT ARTICLES 24/08/2011 | |
AP01 | DIRECTOR APPOINTED DR DEBORAH HARLAND | |
AP01 | DIRECTOR APPOINTED GRAZIANO SEGHEZZI | |
AP01 | DIRECTOR APPOINTED SIMON CHRISTOPHER KERR | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ANDREW WALDRON | |
AA01 | CURRSHO FROM 31/05/2012 TO 31/12/2011 | |
AD01 | REGISTERED OFFICE CHANGED ON 05/09/2011 FROM ANGEL BUILDING 407 ST JOHN STREET LONDON EC1V 4AD ENGLAND | |
SH01 | 24/08/11 STATEMENT OF CAPITAL GBP 760.95 | |
AP03 | SECRETARY APPOINTED MS THEODORA HAROLD | |
RES13 | DIVIDE SHARES INTO £0.0001 AND DIRECTORS AUTHORISED FOR 5 YEARS TO ALLOTT SHARES 27/05/2011 | |
SH01 | 07/06/11 STATEMENT OF CAPITAL GBP 150 | |
AP01 | DIRECTOR APPOINTED DR KEITH STUART BLUNDY | |
SH01 | 27/05/11 STATEMENT OF CAPITAL GBP 150 | |
AP01 | DIRECTOR APPOINTED PROFESSOR STEPHEN PHILIP JACKSON | |
NEWINC | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
Total # Mortgages/Charges | 0 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 0 |
Average | Max | |
MortgagesNumMortCharges | 0.33 | 8 |
MortgagesNumMortOutstanding | 0.17 | 8 |
MortgagesNumMortPartSatisfied | 0.00 | 1 |
MortgagesNumMortSatisfied | 0.16 | 8 |
This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology
MISSION THERAPEUTICS LIMITED owns 2 domain names.
missiontherapeutic.co.uk missiontherapeutics.co.uk
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as MISSION THERAPEUTICS LIMITED are:
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
![]() | 30029010 | Human blood | ||
![]() | 35079030 | Lipoprotein lipase and aspergillus alkaline protease | ||
![]() | 30021010 | Antisera | ||
![]() | 29214900 | Aromatic monoamines and derivatives; salts thereof (excl. aniline, toluidines, diphenylamine, 1-naphthylamine "alpha-naphthylamine", 2-naphthylamine "beta-naphthylamine" and their derivatives, and salts thereof, and amfetamine "INN", benzfetamine "INN", dexamfetamine "INN", etilamfetamine "INN", fencamfamine "INN", lefetamine "INN", levamfetamine "INN", mefenorex "INN" and phentermine "INN", and salts thereof) | ||
![]() | 38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | ||
![]() | 29329900 | Heterocyclic compounds with oxygen hetero-atom[s] only (excl. compounds containing unfused furan ring, whether or not hydrogenated, in the structure, and lactones, isosafrole, 1-[1,3-benzodioxol-5-yl]propan-2-one, piperonal, safrole, tetrahydrocannabinols "all isomers", and inorganic or organic compounds of mercury) | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 29181600 | Gluconic acid, its salts and esters | ||
![]() | 38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | ||
![]() | 38210000 | Prepared culture media for the development or maintenance of micro-organisms "incl. viruses and the like" or of plant, human or animal cells | ||
![]() | 29420000 | Separate chemically defined organic compounds, n.e.s. | ||
![]() | 38210000 | Prepared culture media for the development or maintenance of micro-organisms "incl. viruses and the like" or of plant, human or animal cells | ||
![]() | 38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) | ||
![]() | 29349990 | Nucleic acids and their salts, whether or not chemically defined; heterocyclic compounds (excl. those with oxygen or nitrogen hetero-atom"s" only, compounds containing in the structure an unfused thiazole ring or a benzothiazole or phenothiazine ring-system or further fused, aminorex "INN", brotizolam "INN", clotiazepam "INN", cloxazolam "INN", dextromoramide "INN", haloxazolam "INN", ketazolam "INN", mesocarb "INN", oxazolam "INN", pemoline "INN", phendimetrazine "INN", phenmetrazine "INN", suf | ||
![]() | 38220000 | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, and certified reference materials (excl. compound diagnostic reagents designed to be administered to the patient, blood-grouping reagents, animal blood prepared for therapeutic, prophylactic or diagnostic uses and vaccines, toxins, cultures of micro-organisms and similar products) |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
Category | Award/Grant | |
---|---|---|
Identifying deubiquitylating enzymes (DUBs) as targets for treating of platinum-resistant ovarian cancer : Feasibility Study | 2013-04-01 | £ 144,030 |
How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |